VEGFA and ovarian cancer: Our results demonstrated that SPR965 inhibited cell invasion through reduction of EMT processes and reduced serum VEGF production and expression of VEGF in ovarian tumors in KpB mice, indicating that SPR965 may be a promising agent in the prevention of ovarian cancer metastasis.